Literature DB >> 23895897

Elevated IgE and atopy in patients treated for early-onset ADA-SCID.

Monica G Lawrence1, John S Barber, Robert A Sokolic, Elizabeth K Garabedian, Avanti N Desai, Michelle O'Brien, Nina Jones, Pawan Bali, Michael S Hershfield, Kelly D Stone, Fabio Candotti, Joshua D Milner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23895897      PMCID： PMC3844080          DOI： 10.1016/j.jaci.2013.05.040

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

1.  Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling.

Authors:  S G Apasov; M R Blackburn; R E Kellems; P T Smith; M V Sitkovsky
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 2.  Altered T-cell receptor signaling in the pathogenesis of allergic disease.

Authors:  Shrimati Datta; Joshua D Milner
Journal:  J Allergy Clin Immunol       Date:  2011-02       Impact factor: 10.793

3.  Elevation of serum IgE level and peripheral eosinophil count during T lymphocyte-directed gene therapy for ADA deficiency: implication of Tc2-like cells after gene transduction procedure.

Authors:  N Kawamura; T Ariga; M Ohtsu; M Yamada; A Tame; H Furuta; I Kobayashi; M Okano; Y Yanagihara; Y Sakiyama
Journal:  Immunol Lett       Date:  1998-11       Impact factor: 3.685

Review 4.  Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency.

Authors:  Kerstin Felgentreff; Ruy Perez-Becker; Carsten Speckmann; Klaus Schwarz; Krzysztof Kalwak; Gasper Markelj; Tadej Avcin; Waseem Qasim; E G Davies; Tim Niehues; Stephan Ehl
Journal:  Clin Immunol       Date:  2011-05-30       Impact factor: 3.969

5.  Highly variable clinical phenotypes of hypomorphic RAG1 mutations.

Authors:  Elizabeth Mannino Avila; Gulbu Uzel; Amy Hsu; Joshua D Milner; Maria L Turner; Stefania Pittaluga; Alexandra F Freeman; Steven M Holland
Journal:  Pediatrics       Date:  2010-10-18       Impact factor: 7.124

6.  Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients.

Authors:  Barbara Cassani; Massimiliano Mirolo; Federica Cattaneo; Ulrike Benninghoff; Michael Hershfield; Filippo Carlucci; Antonella Tabucchi; Claudio Bordignon; Maria Grazia Roncarolo; Alessandro Aiuti
Journal:  Blood       Date:  2008-01-24       Impact factor: 22.113

Review 7.  How I treat ADA deficiency.

Authors:  H Bobby Gaspar; Alessandro Aiuti; Fulvio Porta; Fabio Candotti; Michael S Hershfield; Luigi D Notarangelo
Journal:  Blood       Date:  2009-07-28       Impact factor: 22.113

Review 8.  The role of lymphocytes in allergic disease.

Authors:  S Romagnani
Journal:  J Allergy Clin Immunol       Date:  2000-03       Impact factor: 10.793

Review 9.  Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets.

Authors:  Hidehiro Yamane; William E Paul
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988
  9 in total
  9 in total

Review 1.  Eosinophilia Associated with Disorders of Immune Deficiency or Immune Dysregulation.

Authors:  Kelli W Williams; Joshua D Milner; Alexandra F Freeman
Journal:  Immunol Allergy Clin North Am       Date:  2015-08       Impact factor: 3.479

2.  Allergic manifestations of inborn errors of immunity and their impact on the diagnosis: A worldwide study.

Authors:  Zeinab A El-Sayed; Dalia H El-Ghoneimy; José A Ortega-Martell; Nesrine Radwan; Juan C Aldave; Waleed Al-Herz; Maryam A Al-Nesf; Antonio Condino-Neto; Theresa Cole; Brian Eley; Nahla H H Erwa; Sara Espinosa-Padilla; Emilia Faria; Nelson A Rosario Filho; Ramsay Fuleihan; Nermeen Galal; Elizabeth Garabedian; Mary Hintermeyer; Kohsuke Imai; Carla Irani; Ebtihal Kamal; Nadia Kechout; Adam Klocperk; Michael Levin; Tomas Milota; Monia Ouederni; Roberto Paganelli; Claudio Pignata; Farah N Qamar; Isabella Quinti; Sonia Qureshi; Nita Radhakrishnan; Nima Rezaei; John Routes; Surjit Singh; Sangeetha Siniah; Intisar Abdel-Hakam Taha; Luciana K Tanno; Ben Van Dort; Alla Volokha; Kathleen Sullivan
Journal:  World Allergy Organ J       Date:  2022-06-17       Impact factor: 5.516

Review 3.  Advances in basic and clinical immunology in 2013.

Authors:  Javier Chinen; Luigi D Notarangelo; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2014-02-28       Impact factor: 10.793

Review 4.  Genetics of allergy and allergic sensitization: common variants, rare mutations.

Authors:  Klaus Bønnelykke; Rachel Sparks; Johannes Waage; Joshua D Milner
Journal:  Curr Opin Immunol       Date:  2015-09-18       Impact factor: 7.486

Review 5.  Inborn errors of immunity with atopic phenotypes: A practical guide for allergists.

Authors:  Riccardo Castagnoli; Vassilios Lougaris; Giuliana Giardino; Stefano Volpi; Lucia Leonardi; Francesco La Torre; Silvia Federici; Stefania Corrente; Bianca Laura Cinicola; Annarosa Soresina; Caterina Cancrini; Gian Luigi Marseglia; Fabio Cardinale
Journal:  World Allergy Organ J       Date:  2021-02-22       Impact factor: 4.084

6.  Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety.

Authors:  Maria Pia Cicalese; Francesca Ferrua; Laura Castagnaro; Katie Rolfe; Erika De Boever; Rickey R Reinhardt; Jonathan Appleby; Maria Grazia Roncarolo; Alessandro Aiuti
Journal:  Mol Ther       Date:  2018-01-04       Impact factor: 11.454

Review 7.  Diagnostic Challenges in Patients with Inborn Errors of Immunity with Different Manifestations of Immune Dysregulation.

Authors:  Karolina Pieniawska-Śmiech; Gerard Pasternak; Aleksandra Lewandowicz-Uszyńska; Marek Jutel
Journal:  J Clin Med       Date:  2022-07-20       Impact factor: 4.964

Review 8.  Patterns of Allergic Sensitization in High IgE Syndromes.

Authors:  Monica G Lawrence
Journal:  Curr Allergy Asthma Rep       Date:  2015-12       Impact factor: 4.919

Review 9.  Primary atopic disorders.

Authors:  Jonathan J Lyons; Joshua D Milner
Journal:  J Exp Med       Date:  2018-03-16       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.